Consequences of local recurrence of soft tissue sarcoma: 205 patients from the Scandinavian Sarcoma Group Register

Acta Orthop Scand. 2000 Oct;71(5):488-95. doi: 10.1080/000164700317381199.

Abstract

From the Scandinavian Sarcoma Group Register, information on 1,224 surgically-treated patients with soft tissue sarcoma (STS) of the extremity or trunk wall, diagnosed between 1987 and 1995, was collected. 205 patients, one third of whom were referred to a center with a local recurrence, had a total of 284 local recurrences. This analysis describes the treatment for these local recurrences, complications and risk of further recurrences. 169 patients were surgically treated for their first local recurrence. An intralesional or marginal margin was achieved in 110 of these patients, 59 of whom were also given radiotherapy. 54 of the 169 patients had a second local recurrence. The second local recurrence rate was 0.50 if the first local recurrence had been treated with only surgery with a marginal margin, compared to 0.28 if treated with surgery with a marginal margin and radiotherapy or with a wide margin (p = 0.0008). In extremity STS, the crude amputation rate for local recurrences was 0.22 (31 of 142)-i.e., higher than for primary tumors 0.09 (96 of 1065) (p < 0.0001). A high local recurrence rate after treatment outside of sarcoma centers has earlier been shown. We conclude that the consequences of local recurrence in terms of morbidity and costs justifies referral of STS patients for multidisciplinary evaluation and multimodality treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amputation, Surgical
  • Combined Modality Therapy
  • Female
  • Humans
  • Leg
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local* / economics
  • Neoplasm Recurrence, Local* / epidemiology
  • Neoplasm Recurrence, Local* / radiotherapy
  • Neoplasm Recurrence, Local* / surgery
  • Registries
  • Sarcoma / economics
  • Sarcoma / epidemiology
  • Sarcoma / radiotherapy
  • Sarcoma / surgery*
  • Soft Tissue Neoplasms / economics
  • Soft Tissue Neoplasms / epidemiology
  • Soft Tissue Neoplasms / radiotherapy
  • Soft Tissue Neoplasms / surgery*
  • Sweden / epidemiology